DRI Healthcare
Their stated focus (public profile)
DRI Healthcare is a pioneer in global pharmaceutical royalty monetization, acquiring patent-protected royalty streams derived from the sales of important drugs across multiple therapeutic areas. The firm provides capital to biopharmaceutical innovators—including inventors, academic institutions, nonprofits, and biotech/biopharma companies—in exchange for royalty interests in medically necessary, market-leading medicines. It focuses on long-duration, patent-protected assets with significant clinical benefits and high growth potential, building a diversified portfolio with over $3.0 billion deployed across 77 royalties on 50 drugs.
Sectors: Healthtech, Life sciences
On file: 15 partners on record
Website: drihealthcare.com
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Is this your fund? Request a correction or removal.
Search the funds we have on file
Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.
Looking to claim your own fund? Start here →
This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.
Funds closest to this thesis
Ordered by how close each thesis sits to this one.
Is this your fund? Request a correction or removal.